查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786839

糖尿病酮酸症(DKA)治療的全球市場，規模，佔有率，趨勢，產業分析報告:各治療類型，各用途，各終端用戶，各地區 - 市場預測，2025年～2034年

Diabetic Ketoacidosis Treatment Market Size, Share, Trends, & Industry Analysis Report By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，糖尿病酮症酸中毒 (DKA) 治療市場預計到 2034 年將達到 12.9208 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

糖尿病酮症酸中毒 (DKA) 治療對於糾正第 1 型糖尿病患者急性糖尿病急症期間的代謝失衡至關重要。標準治療包括靜脈注射胰島素以穩定高血糖和酸中毒、液體復甦和電解質補充。胰島素類似物、連續血糖監測設備和即時電解質管理的進步正在改善醫院、ICU 和門診的治療效果。

糖尿病酮症酸中毒 (DKA) 治療市場的成長主要得益於全球 1 型糖尿病盛行率的上升，以及急診環境中數位健康平台的日益普及。此外，不斷擴展的門診急診基礎設施和由付費方支持的分散式醫療模式正在加速新興經濟體和已開發經濟體的採用。

糖尿病酮酸中毒 (DKA) 治療市場報告重點

按治療類型劃分，胰島素療法在 2024 年佔市場主導地位，因為它繼續作為緊急 DKA 方案中快速降低血糖的一線治療手段。

按應用劃分，成人市場在 2024 年佔市場主導地位，因為成年人群中與胰島素漏服、合併症和糖尿病管理延遲相關的住院率不斷上升。

以最終用戶劃分，醫院細分市場在2024年佔了市場主導地位。這得歸功於醫院在管理重症和復發性糖尿病酮症酸中毒 (DKA) 病例方面擁有全面的實力，並輔以先進的診斷技術、靜脈注射治療和重症監護人員。

預計到2024年，北美將佔糖尿病酮症酸中毒 (DKA) 治療市場的大部分佔有率，這得益於動態血糖監測 (CGM) 的廣泛採用、胰島素輸送系統的數位化以及標準化治療方案的遵循。

由於第1型糖尿病的盛行率不斷上升以及公共醫療部門對急性糖尿病治療的投資，亞太地區佔了相當大的市場佔有率。

全球主要市場參與者包括諾和諾德公司、賽諾菲、禮來公司、碧迪公司、德康醫療公司、美敦力公司、羅氏公司、雅培實驗室、Insulet公司、Tandem Diabetes公司Care, Inc.、Ypsomed AG 和 Glenmark Pharmaceuticals Ltd.

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球糖尿病酮酸症(DKA)治療市場洞察

  • 市場概述
  • 糖尿病酮酸症(DKA)治療市場動態
    • 促進因素和機會
      • 全球第 1 型糖尿病盛行率上升
      • 數位健康平台在急診護理的整合
    • 限制因素與課題
      • 急診護理的高成本負擔基礎設施
  • PESTEL分析
  • 糖尿病酮酸症(DKA)治療市場趨勢
  • 價值鏈分析

第5章 全球糖尿病酮酸症(DKA)治療市場:各治療類型

  • 主要調查結果
  • 簡介
  • 胰島素療法
  • 水分供給
  • 電解質供給

第6章 全球糖尿病酮酸症(DKA)治療市場:各用途

  • 主要調查結果
  • 簡介
  • 兒童
  • 成人

第7章 全球糖尿病酮酸症(DKA)治療市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 專門診所
  • 門診病人診療中心
  • 醫院

第8章 全球糖尿病酮酸症(DKA)治療市場:各地區

  • 主要調查結果
  • 簡介
    • 糖尿病酮酸症(DKA)治療市場分析:各地區，2020年～2034年
  • 北美
    • 北美:各治療類型，2020～2034年
    • 北美:各用途，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各治療類型，2020～2034年
    • 歐洲:各用途，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各治療類型，2020年～2034年
    • 亞太地區:各用途，2020～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各治療類型，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各治療類型，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company(BD)
  • Dexcom, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Glenmark Pharmaceuticals Ltd
  • Insulet Corporation
  • Medtronic plc
  • Novo Nordisk A/S
  • Sanofi
  • Tandem Diabetes Care, Inc.
  • Ypsomed AG

Product Code: PM6065

The diabetic ketoacidosis treatment market size is expected to reach USD 1,292.08 Million by 2034, according to a new study by Polaris Market Research. The report "Diabetic Ketoacidosis Treatment Market Share, Size, Trends, Industry Analysis Report: By Treatment Type, By Application (Pediatric and Adults), By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Diabetic ketoacidosis treatment is essential for correcting metabolic imbalance during acute diabetic emergencies in type 1 diabetes patients. Standard care includes intravenous insulin, fluid resuscitation and electrolyte replacement to stabilize hyperglycemia and acidosis. Advancements in insulin analogs, continuous glucose monitoring device and real-time electrolyte management are enhancing treatment outcomes across hospitals, ICUs and ambulatory care settings.

The growth of the diabetic ketoacidosis treatment market is primarily driven by the rising global prevalence of type 1 diabetes and increased adoption of digital health platforms in acute care settings. Additionally, the expansion of outpatient emergency infrastructure and payer-supported decentralized treatment models are accelerating adoption across developing and developed economies.

Diabetic Ketoacidosis Treatment Market Report Highlights

Based on treatment type, the insulin therapy dominated the market in 2024, owing to its continued use as the first-line intervention for rapid glucose reduction in emergency DKA protocols.

In terms of application, the adult segment dominated the market in 2024. This is driven by higher hospitalization rates linked to insulin omission, comorbidities, and delayed diabetes management in adult populations.

In terms of end user, the hospital segment dominated the market in 2024, owing to its comprehensive capacity to manage severe and recurrent DKA cases with access to advanced diagnostics, IV therapies and critical care staff.

North America accounted for the majority share of the global diabetic ketoacidosis treatment market in 2024, fueled by widespread CGM adoption, digital insulin delivery systems and adherence to standardized treatment protocols support market leadership.

Asia Pacific held significant market share, fueled by growing incidence of type 1 diabetes and public healthcare investments in emergency diabetic care.

A few global key market players include Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Becton, Dickinson and Company (BD), Dexcom, Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Insulet Corporation, Tandem Diabetes Care, Inc., Ypsomed AG, and Glenmark Pharmaceuticals Ltd.

Polaris Market Research has segmented the market report on the basis of treatment type, application, end user, and region:

By Treatment Type Outlook (Revenue, USD Million, 2020-2034)

Insulin Therapy

Fluid Replacement

Electrolyte Replacement

By Application Outlook (Revenue, USD Million, 2020-2034)

Pediatric

Adults

By End User Outlook (Revenue, USD Million, 2020-2034)

Specialty Clinics

Ambulatory Care Center

Hospitals

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Diabetic Ketoacidosis Treatment Market Insights

  • 4.1. Diabetic Ketoacidosis Treatment Market - Market Snapshot
  • 4.2. Diabetic Ketoacidosis Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Type 1 Diabetes Worldwide
      • 4.2.1.2. Integration of Digital Health Platforms in Acute Care Settings
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost Burden of Acute Care Infrastructure
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Diabetic Ketoacidosis Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • 5.3. Insulin Therapy
    • 5.3.1. Global Diabetic Ketoacidosis Treatment Market, by Insulin Therapy, by Region, 2020-2034 (USD Million)
  • 5.4. Fluid Replacement
    • 5.4.1. Global Diabetic Ketoacidosis Treatment Market, by Fluid Replacement, by Region, 2020-2034 (USD Million)
  • 5.5. Electrolyte Replacement
    • 5.5.1. Global Diabetic Ketoacidosis Treatment Market, by Electrolyte Replacement, by Region, 2020-2034 (USD Million)

6. Global Diabetic Ketoacidosis Treatment Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • 6.3. Pediatric
    • 6.3.1. Global Diabetic Ketoacidosis Treatment Market, by Pediatric, by Region, 2020-2034 (USD Million)
  • 6.4. Adults
    • 6.4.1. Global Diabetic Ketoacidosis Treatment Market, by Adults, by Region, 2020-2034 (USD Million)

7. Global Diabetic Ketoacidosis Treatment Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • 7.3. Specialty Clinics
    • 7.3.1. Global Diabetic Ketoacidosis Treatment Market, by Specialty Clinics, by Region, 2020-2034 (USD Million)
  • 7.4. Ambulatory Care Center
    • 7.4.1. Global Diabetic Ketoacidosis Treatment Market, by Ambulatory Care Center, by Region, 2020-2034 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Global Diabetic Ketoacidosis Treatment Market, by Hospitals, by Region, 2020-2034 (USD Million)

8. Global Diabetic Ketoacidosis Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Diabetic Ketoacidosis Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Diabetic Ketoacidosis Treatment Market - North America
    • 8.3.1. North America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.3.4. Diabetic Ketoacidosis Treatment Market - U.S.
      • 8.3.4.1. U.S.: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.3.5. Diabetic Ketoacidosis Treatment Market - Canada
      • 8.3.5.1. Canada: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • 8.4. Diabetic Ketoacidosis Treatment Market - Europe
    • 8.4.1. Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.4. Diabetic Ketoacidosis Treatment Market - UK
      • 8.4.4.1. UK: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.5. Diabetic Ketoacidosis Treatment Market - France
      • 8.4.5.1. France: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.6. Diabetic Ketoacidosis Treatment Market - Germany
      • 8.4.6.1. Germany: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.7. Diabetic Ketoacidosis Treatment Market - Italy
      • 8.4.7.1. Italy: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.8. Diabetic Ketoacidosis Treatment Market - Spain
      • 8.4.8.1. Spain: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.9. Diabetic Ketoacidosis Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.10. Diabetic Ketoacidosis Treatment Market - Russia
      • 8.4.10.1. Russia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.4.11. Diabetic Ketoacidosis Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • 8.5. Diabetic Ketoacidosis Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.4. Diabetic Ketoacidosis Treatment Market - China
      • 8.5.4.1. China: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.5. Diabetic Ketoacidosis Treatment Market - India
      • 8.5.5.1. India: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.6. Diabetic Ketoacidosis Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.7. Diabetic Ketoacidosis Treatment Market - Japan
      • 8.5.7.1. Japan: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.8. Diabetic Ketoacidosis Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.9. Diabetic Ketoacidosis Treatment Market - South Korea
      • 8.5.9.1. South Korea: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.10. Diabetic Ketoacidosis Treatment Market - Australia
      • 8.5.10.1. Australia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.5.11. Diabetic Ketoacidosis Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • 8.6. Diabetic Ketoacidosis Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.6.4. Diabetic Ketoacidosis Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.6.5. Diabetic Ketoacidosis Treatment Market - UAE
      • 8.6.5.1. UAE: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.6.6. Diabetic Ketoacidosis Treatment Market - Israel
      • 8.6.6.1. Israel: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.6.7. Diabetic Ketoacidosis Treatment Market - South Africa
      • 8.6.7.1. South Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.6.8. Diabetic Ketoacidosis Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • 8.7. Diabetic Ketoacidosis Treatment Market - Latin America
    • 8.7.1. Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.7.4. Diabetic Ketoacidosis Treatment Market - Mexico
      • 8.7.4.1. Mexico: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.7.5. Diabetic Ketoacidosis Treatment Market - Brazil
      • 8.7.5.1. Brazil: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.7.6. Diabetic Ketoacidosis Treatment Market - Argentina
      • 8.7.6.1. Argentina: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
    • 8.7.7. Diabetic Ketoacidosis Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dexcom, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Eli Lilly and Company
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Glenmark Pharmaceuticals Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Insulet Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medtronic plc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Novo Nordisk A/S
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Tandem Diabetes Care, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Ypsomed AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

  • Table 1 Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 2 Global Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 4 North America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 5 North America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 7 U.S.: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 10 Canada: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 11 Canada: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 13 Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 14 Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 16 UK: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 17 UK: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 19 France: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 20 France: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 22 Germany: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 23 Germany: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 25 Italy: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 26 Italy: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 28 Spain: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 29 Spain: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 31 Netherlands: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 34 Russia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 35 Russia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 43 China: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 44 China: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 46 India: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 47 India: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 49 Malaysia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 52 Japan: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 53 Japan: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 55 Indonesia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 58 South Korea: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 61 Australia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 62 Australia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 73 UAE: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 74 UAE: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 76 Israel: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 77 Israel: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 79 South Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 85 Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 88 Mexico: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 91 Brazil: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 94 Argentina: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Diabetic Ketoacidosis Treatment Market, by End User, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Diabetic Ketoacidosis Treatment Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment Type
  • Figure 7. Global Diabetic Ketoacidosis Treatment Market, by Treatment Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Diabetic Ketoacidosis Treatment Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Diabetic Ketoacidosis Treatment Market, by End User, 2024 & 2034 (USD Million)